Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Liabilities and Shareholders Equity (2018 - 2025)

Nexgel (NXGL) has disclosed Liabilities and Shareholders Equity for 8 consecutive years, with $11.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity rose 9.91% year-over-year to $11.6 million, compared with a TTM value of $42.8 million through Sep 2025, up 5.07%, and an annual FY2024 reading of $11.0 million, up 10.33% over the prior year.
  • Liabilities and Shareholders Equity was $11.6 million for Q3 2025 at Nexgel, up from $9.7 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $17.0 million in Q4 2021 and bottomed at $3.4 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $10.2 million, with a median of $10.4 million recorded in 2025.
  • The sharpest move saw Liabilities and Shareholders Equity skyrocketed 652.46% in 2021, then crashed 39.02% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $17.0 million in 2021, then plummeted by 39.02% to $10.4 million in 2022, then dropped by 3.88% to $10.0 million in 2023, then grew by 10.33% to $11.0 million in 2024, then grew by 5.8% to $11.6 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for NXGL at $11.6 million in Q3 2025, $9.7 million in Q2 2025, and $10.4 million in Q1 2025.